GlassScriptPhysician profile
Sandra Daskalakis
NPI 1912395526
$1,651.70
in general payments reported to CMS, 2019-2025
17 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $381 · 2023: $398 · 2024: $424 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $517.68 | 2021-2025 | Lifevest |
| Amgen INC. | $243.33 | 2022-2025 | Repatha |
| Boston Scientific Corporation | $178.77 | 2022-2025 | Watchman Flx |
| Actelion Pharmaceuticals US, INC. | $115.35 | 2022-2025 | Opsumit, Uptravi |
| Pfizer INC. | $82.96 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $62.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.85 | 2022-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $56.17 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $55.07 | 2023-2024 | Verquvo, Winrevair |
| Sanofi-Aventis U.S. LLC | $54.03 | 2022-2023 | |
| Impulse Dynamics (USA) INC. | $44.04 | 2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $40.34 | 2023 | Evkeeza |
| Esperion Therapeutics, INC. | $34.33 | 2021 | |
| Janssen Pharmaceuticals, INC | $33.92 | 2021-2024 | Xarelto |
| Celgene Corporation | $33.40 | 2022-2024 | Camzyos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.23 | 2021 | |
| Kestra Medical Technology Services, INC. | $18.99 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Daskalakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.